BioSpace News Archive

LumiThera Inc. announced positive findings in its LIGHTSITE III, multi-center clinical trial in non-neovascular Age-Related Macular Degeneration subjects treated with the Valeda® Light Delivery System.

AlzeCure Pharma AB announced that two abstracts on its research platform NeuroRestore have been accepted for poster presentation at the 2nd Swedish Meeting for Alzheimer Research, which this year will be held in Stockholm on April 21.

RadNet, Inc. announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the Sidoti & Company Spring 2022 Conference on Thursday, March 24th at 01:00 p.m. Eastern Time.

MannKind Corporation announced that its Chief Scientific Officer, Thomas Hofmann, MD, PhD, will participate in the Cantor Virtual Rare Orphan Disease Summit on Tuesday, March 29, 2022 at 8:00 am.

Lung Therapeutics, Inc. announced the successful completion of a Phase 1a clinical trial for LTI-03, a Caveolin-1-related peptide designed to treat idiopathic pulmonary fibrosis.

ECP Pharma is a global company with operations in the United States, Canada, and Latin America that is committed to research, development & manufacturing of innovative drug products that enhance human life.

ITM Isotope Technologies Munich SE, a leading radiopharmaceutical biotech company, announced the successful closing of an equity investment totaling EUR 33 million from the Indigenous Critical Infrastructure Fund Canada and from a private equity fund managed by Portland Investment Counsel Inc., a related and connected party to Portland Holdings.

Evaxion Biotech A/S announced the fourth quarter and full-year 2021 financial results and provided an operational update.

Pyxis Oncology, Inc. announced it will host a conference call and live webcast on Tuesday, March 29, 2022 at 8:00 a.m. ET to discuss recent corporate updates.

DarioHealth Corp., a leader in the global digital therapeutics market, reported financial results for the fourth quarter and full year 2021 and provided a corporate and commercial update.